Management of patients with adrenal myelolipoma: experience from a tertiary referral centre.
Adrenal
Adrenal surgery
Adrenal surveillance
Adrenalectomy
Incidentalomas
Myelolipoma
Journal
Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
13
06
2024
accepted:
02
08
2024
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
4
9
2024
Statut:
aheadofprint
Résumé
Adrenal myelolipomas are rare, benign, tumours of the adrenal cortex. This study reports the experience of a tertiary adrenal surgery referral centre's approach to the management of patients with adrenal myelolipoma. A retrospective observational cohort study was conducted on all adult patients (> 18 years age) diagnosed with adrenal myelolipoma from January 1, 2014, to December 30, 2022. Demographics, imaging characteristics, histological diagnosis (where applicable) and follow-up data were compared between patients undergoing surgery and those referred to surveillance. Indications for operative intervention were recorded at the time of multidisciplinary team discussion, consisting of surgeons, endocrinology physicians, radiologists, pathologists and specialist nursing representatives. Of the 522 patients with an adrenal lesion discussed in adrenal tumour meeting between 2014 and 2022, n = 15 (2.8%) were diagnosed with adrenal myelolipoma. Of the 15 patients, 4 underwent adrenalectomy at first presentation (27%), while 1 patient underwent adrenalectomy after interval follow-up. Indications for operative intervention were as follows: 'indeterminate lesion' (n = 3), 'abdominal pain and size (> 4 cm)' (n = 1) and 'mass effect on adjacent organs' (n = 1). The mean rate of lesion growth in patients referred for surveillance (n = 10) was 0.13 cm/year. Histology confirmed adrenal myelolipoma as the diagnosis in all resected tumours. For patients with adrenal myelolipoma, the presence of symptoms and/or indeterminate features on imaging may be more clinically useful indications for operative intervention over size alone. The surveillance of adrenal myelolipomas, even in patients with adrenal lesions > 4 cm, is a safe clinical strategy, provided the imaging characteristics are benign and patients remain asymptomatic.
Sections du résumé
BACKGROUND
BACKGROUND
Adrenal myelolipomas are rare, benign, tumours of the adrenal cortex.
AIMS
OBJECTIVE
This study reports the experience of a tertiary adrenal surgery referral centre's approach to the management of patients with adrenal myelolipoma.
METHODS
METHODS
A retrospective observational cohort study was conducted on all adult patients (> 18 years age) diagnosed with adrenal myelolipoma from January 1, 2014, to December 30, 2022. Demographics, imaging characteristics, histological diagnosis (where applicable) and follow-up data were compared between patients undergoing surgery and those referred to surveillance. Indications for operative intervention were recorded at the time of multidisciplinary team discussion, consisting of surgeons, endocrinology physicians, radiologists, pathologists and specialist nursing representatives.
RESULTS
RESULTS
Of the 522 patients with an adrenal lesion discussed in adrenal tumour meeting between 2014 and 2022, n = 15 (2.8%) were diagnosed with adrenal myelolipoma. Of the 15 patients, 4 underwent adrenalectomy at first presentation (27%), while 1 patient underwent adrenalectomy after interval follow-up. Indications for operative intervention were as follows: 'indeterminate lesion' (n = 3), 'abdominal pain and size (> 4 cm)' (n = 1) and 'mass effect on adjacent organs' (n = 1). The mean rate of lesion growth in patients referred for surveillance (n = 10) was 0.13 cm/year. Histology confirmed adrenal myelolipoma as the diagnosis in all resected tumours.
CONCLUSIONS
CONCLUSIONS
For patients with adrenal myelolipoma, the presence of symptoms and/or indeterminate features on imaging may be more clinically useful indications for operative intervention over size alone. The surveillance of adrenal myelolipomas, even in patients with adrenal lesions > 4 cm, is a safe clinical strategy, provided the imaging characteristics are benign and patients remain asymptomatic.
Identifiants
pubmed: 39230649
doi: 10.1007/s11845-024-03779-2
pii: 10.1007/s11845-024-03779-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Lam AK (2017) Lipomatous tumours in adrenal gland: WHO updates and clinical implications. Endocr Relat Cancer 24(3):R65–R79
doi: 10.1530/ERC-16-0564
pubmed: 28143811
Bin X et al (2011) Adrenal incidentalomas: experience from a retrospective study in a Chinese population. Urol Oncol: Semin Orig Inv 29(3):270–274
doi: 10.1016/j.urolonc.2009.03.027
Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190(5):1163–1168
doi: 10.2214/AJR.07.2799
pubmed: 18430826
Decmann A et al. (2018) Adrenal myelolipoma: a comprehensive review. Endocrine 59(1):7–15
doi: 10.1007/s12020-017-1473-4
pubmed: 29164520
Calissendorff J et al. (2021) Adrenal myelolipomas. Lancet Diabetes Endocrinol 9(11):767–775
doi: 10.1016/S2213-8587(21)00178-9
pubmed: 34450092
pmcid: 8851410
Steka X et al. (2022) Adrenal myelolipoma: defining the role of surgery. A case report. Int J Surg Case Rep 98:107527
doi: 10.1016/j.ijscr.2022.107527
pubmed: 36030765
pmcid: 9434030
Hamidi O et al. (2020) Clinical course of adrenal myelolipoma: a long-term longitudinal follow-up study. Clin Endocrinol 93(1):11–18
doi: 10.1111/cen.14188
Han M et al. (1997) The natural history and treatment of adrenal myelolipoma. J Urol 157(4):1213–1216
doi: 10.1016/S0022-5347(01)64926-7
pubmed: 9120904
Campbell MJ et al. (2017) The radiographically diagnosed adrenal myelolipoma: what do we really know? Endocrine 58(2):289–294
doi: 10.1007/s12020-017-1410-6
pubmed: 28866749
Shenoy VG et al (2015) Adrenal myelolipoma: controversies in its management. Indian J Urol 31(2):94–101
doi: 10.4103/0970-1591.152807
pubmed: 25878407
pmcid: 4397562
Sieber SC et al. (1989) Ectopic ACTH and adrenal myelolipoma. Conn Med 53(1):7–10
pubmed: 2539944
Sanders R et al. (1995) Clinical spectrum of adrenal myelolipoma: analysis of 8 tumors in 7 patients. J Urol 153(6):1791–1793
doi: 10.1016/S0022-5347(01)67307-5
pubmed: 7752318
Hoeffel CC, Kowalski S (2000) Giant myelolipoma of the adrenal gland: natural history. Clin Radiol 55(5):1–3
doi: 10.1053/crad.2000.0089
pubmed: 10816392
Gershuni VM et al. (2014) Adrenal myelolipoma: operative indications and outcomes. J Laparoendosc Adv Surg Tech A 24(1):8–12
doi: 10.1089/lap.2013.0411
pubmed: 24328509
pmcid: 3931430
Kiriakopoulos A, Tsakayannis D, Linos D (2006) Surgical management of adrenal myelolipoma: a series of 10 patients and review of the literature. Minerva Chir 61(3):241–246
pubmed: 16858306
Alkhalifa AM et al. (2020) Lipomatous tumors of adrenal gland: a case series of 5 patients and review of the literature. Int J Surg Case Rep 67:54–61
doi: 10.1016/j.ijscr.2020.01.027
pubmed: 32007865
pmcid: 7000441
Weber F et al. (2019) Surgery for adrenal angiomyelolipoma: an individualized concept. Langenbecks Arch Surg 404(4):403–409
doi: 10.1007/s00423-019-01783-0
pubmed: 30972487
Ramirez M, Misra S (2014) Adrenal myelolipoma: to operate or not? A case report and review of the literature. Int J Surg Case Rep 5(8):494–496
doi: 10.1016/j.ijscr.2014.04.001
pubmed: 24995663
pmcid: 4147662
Zhao J et al. (2014) The diagnosis and treatment of primary adrenal lipomatous tumours in Chinese patients: a 31-year follow-up study. Can Urol Assoc J 8(3–4):E132–E136
pubmed: 24678351
pmcid: 3956831
Terzolo M et al. (2009) Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 23(2):233–243
doi: 10.1016/j.beem.2009.04.001
pubmed: 19500766
Ichijo T et al. (2020) A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features. Endocr J 67(2):141–152
doi: 10.1507/endocrj.EJ18-0486
pubmed: 31694993
Mantero F et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85(2):637–44
pubmed: 10690869
Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am J Roentgenol 190(5):1163–1168
doi: 10.2214/AJR.07.2799
Lam KY, Lo CY (2001) Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol 54(9):707–712
doi: 10.1136/jcp.54.9.707
pubmed: 11533079
pmcid: 1731508
Lin L et al. (2021) Adrenal myelolipoma: 369 cases from a high-volume center. Front Cardiovasc Med 8:663346
doi: 10.3389/fcvm.2021.663346
pubmed: 34568440
pmcid: 8462508
Yin L et al. (2014) A 10-year single-center experience with surgical management of adrenal myelolipoma. J Endourol 28(2):252–255
doi: 10.1089/end.2013.0283
pubmed: 24044410
Castillo OA et al. (2007) Laparoscopic adrenalectomy for adrenal myelolipoma. Arch Esp Urol 60(2):217–221
doi: 10.4321/S0004-06142007000200022
pubmed: 17484497
Fassnacht M et al. (2016) Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1–G34
doi: 10.1530/EJE-16-0467
pubmed: 27390021
Melck AL et al. (2012) Immediate laparoscopic adrenalectomy versus observation: cost evaluation for incidental adrenal lesions with atypical imaging characteristics. Am J Surg 204(4):462–467
doi: 10.1016/j.amjsurg.2012.02.009
pubmed: 22591697
Al-Brahim N, Asa S (2007) Myelolipoma with adrenocortical adenoma: an unusual combination that can resemble carcinoma. Endocr Pathol 18(2):103–105
doi: 10.1007/s12022-007-0019-3
pubmed: 17917001
Robinson DA et al (2022) Adrenal myelolipoma masquerading as an adrenal malignancy. Case Rep Endocrinol Print 2022:4044602